| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.08 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.11 | 0.06 |